Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

48.88
Delayed Data
As of 3:59pm ET
 +2.40 / +5.16%
Today’s Change
24.58
Today|||52-Week Range
60.01
+2.20%
Year-to-Date

Today’s Trading

Previous close46.48
Today’s open46.52
Day’s range46.47 - 49.00
Volume974,664
Average volume (3 months)1,397,422
Market cap$5.8B
Dividend yield--
Data as of 3:59pm ET, 08/22/2017

Growth & Valuation

Earnings growth (last year)+2.70%
Earnings growth (this year)+69.68%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+22.18%
P/E ratio232.8
Price/Sales16.69
Price/Book56.78

Competitors

 Today’s
change
Today’s
% change
UTHRUnited Therapeutics ...+1.47+1.13%
GRFSGrifols SA+0.19+0.94%
TSROTESARO Inc+1.76+1.48%
PTHNPatheon NV-0.04-0.11%
Data as of 4:03pm ET, 08/22/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$346.6M
Annual profit (last year)-$86.6M
Net profit margin-24.97%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer &
Inside Director
B. Lynne Parshall
Corporate headquarters
Carlsbad, California

Forecasts